Tradestie Institutional Equity Comparison Engine

MIRM vs ELDN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MIRM Overall Edge

MIRM Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mirum Pharmaceuticals, Inc. Common Stock (MIRM) driven by superior Momentum & Technical, Options & Structure while ELDN counters with relative strength in Valuation, Growth & Margin. Fundamentally, MIRM trades at N/M Forward P/E with -21.6% operating margin (+39.6% YoY revenue) versus ELDN at 5.4x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MIRM sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against ELDN sits in BREAKDOWN (28th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ELDN
MIRM N/M vs ELDN 5.4x Fwd P/E
Growth & Margin Winner ELDN
Op Margin -21.6% vs 0.0% ยท YoY +39.6% vs +0.0%
Momentum & Technical Winner MIRM
1Y +36.5% vs +14.8% ยท 52W Pos 49% vs 14%
Options & Structure Winner MIRM
CONSOLIDATION (15th %ile IV) vs BREAKDOWN (28th %ile IV)
MIRM NASDAQ
Mirum Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$96.13
+0.65% 1D
Market Cap $6.2B
1M Return +15.68%
1Y Return +36.48%
Forward P/E N/M
Unified AI Score
51.1 / 100 HOLD
Tech 43.0 Fund 56.0 Flow 68.0 Mom 60.0
ELDN NASDAQ
Eledon Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$1.78
-6.32% 1D
Market Cap $160.5M
1M Return -22.61%
1Y Return +14.84%
Forward P/E 5.4x
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 64.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MIRM +36.48% ELDN +14.84% Spread: +21.64 pp (MIRM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MIRM TTM Op. Margin: -21.6% ELDN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MIRM vs ELDN. Trailing 12-month operating profitability (MIRM -21.6% vs ELDN 0.0%) and valuation multiples (MIRM N/M vs ELDN 5.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MIRM (5) vs ELDN (5)
Institutional Metric MIRM ELDN Criterion Row Winner
Market Capitalization Scale $6.2B $160.5M Larger Scale MIRM
Trailing P/E Ratio Valuation N/M 5.4x Lower Multiple ELDN
Forward P/E Ratio Valuation N/M 5.4x Lower Multiple ELDN
Revenue Growth (YoY) Growth +39.6% +0.0% Higher Growth MIRM
Operating Margin (TTM) Profitability -21.6% 0.0% Higher Margin ELDN
Net Profit Margin Profitability -134.8% 0.0% Higher Margin ELDN
Return on Equity (ROE) Capital Efficiency -760.0% -105.7% Higher ROE ELDN
52-Week Range Position Momentum 49% ($63โ€“$130) 14% ($1โ€“$4) Stronger Trend MIRM
Beta / 30D Volatility Risk Regime 0.86ฮฒ ยท 48% Vol 1.78ฮฒ ยท 116% Vol Lower Realized Risk MIRM
Unified Institutional Score Composite Signal 51.1 / 100 (HOLD) 44.3 / 100 (HOLD) Higher Composite MIRM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MIRM vs ELDN Buy Guide
MIRM CONSOLIDATION
96d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live MIRM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ELDN BREAKDOWN
150d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 28th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ELDN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MIRM nor ELDN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.